[DPHARMA] QoQ Cumulative Quarter Result on 31-Mar-2013 [#1]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
27-May-2013
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2013
Quarter
31-Mar-2013 [#1]
Profit Trend
QoQ- -74.25%
YoY- -0.13%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Cumulative Result
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
Revenue 162,405 116,671 75,826 37,837 135,310 99,932 70,412 74.30%
PBT 40,175 31,017 21,963 8,956 35,298 26,298 17,906 71.13%
Tax -7,900 -6,842 -4,575 -2,257 -9,284 -6,281 -4,331 49.12%
NP 32,275 24,175 17,388 6,699 26,014 20,017 13,575 77.85%
-
NP to SH 32,275 24,175 17,388 6,699 26,014 20,017 13,575 77.85%
-
Tax Rate 19.66% 22.06% 20.83% 25.20% 26.30% 23.88% 24.19% -
Total Cost 130,130 92,496 58,438 31,138 109,296 79,915 56,837 73.45%
-
Net Worth 181,850 179,125 187,340 176,143 169,354 167,965 162,400 7.81%
Dividend
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
Div 24,293 - 5,550 - 19,434 - 4,858 191.56%
Div Payout % 75.27% - 31.92% - 74.71% - 35.79% -
Equity
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
Net Worth 181,850 179,125 187,340 176,143 169,354 167,965 162,400 7.81%
NOSH 138,817 138,856 138,770 138,695 138,815 138,814 138,803 0.00%
Ratio Analysis
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
NP Margin 19.87% 20.72% 22.93% 17.70% 19.23% 20.03% 19.28% -
ROE 17.75% 13.50% 9.28% 3.80% 15.36% 11.92% 8.36% -
Per Share
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
RPS 116.99 84.02 54.64 27.28 97.47 71.99 50.73 74.28%
EPS 23.25 17.41 12.53 4.83 18.74 14.42 9.78 77.84%
DPS 17.50 0.00 4.00 0.00 14.00 0.00 3.50 191.54%
NAPS 1.31 1.29 1.35 1.27 1.22 1.21 1.17 7.80%
Adjusted Per Share Value based on latest NOSH - 138,695
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
RPS 16.88 12.13 7.88 3.93 14.07 10.39 7.32 74.27%
EPS 3.36 2.51 1.81 0.70 2.70 2.08 1.41 78.12%
DPS 2.53 0.00 0.58 0.00 2.02 0.00 0.51 190.02%
NAPS 0.189 0.1862 0.1948 0.1831 0.1761 0.1746 0.1688 7.80%
Price Multiplier on Financial Quarter End Date
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
Date 31/12/13 30/09/13 28/06/13 29/03/13 31/12/12 28/09/12 29/06/12 -
Price 2.58 2.55 2.38 2.23 2.13 2.36 2.23 -
P/RPS 2.21 3.03 4.36 8.17 2.19 3.28 4.40 -36.73%
P/EPS 11.10 14.65 18.99 46.17 11.37 16.37 22.80 -38.03%
EY 9.01 6.83 5.26 2.17 8.80 6.11 4.39 61.28%
DY 6.78 0.00 1.68 0.00 6.57 0.00 1.57 164.48%
P/NAPS 1.97 1.98 1.76 1.76 1.75 1.95 1.91 2.07%
Price Multiplier on Announcement Date
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
Date 26/02/14 19/11/13 28/08/13 27/05/13 25/02/13 23/11/12 16/08/12 -
Price 2.60 2.56 2.44 2.51 2.17 2.28 2.38 -
P/RPS 2.22 3.05 4.47 9.20 2.23 3.17 4.69 -39.18%
P/EPS 11.18 14.70 19.47 51.97 11.58 15.81 24.34 -40.38%
EY 8.94 6.80 5.14 1.92 8.64 6.32 4.11 67.64%
DY 6.73 0.00 1.64 0.00 6.45 0.00 1.47 174.95%
P/NAPS 1.98 1.98 1.81 1.98 1.78 1.88 2.03 -1.64%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment